VANECK PHARMACEUTICAL ETF (PPH:NASDAQ)
$114.4061 0.2961 (0.2595%)
Analysed VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) News Sources
4 ETF Winners of June Likely to Gain in July
08-07-2026
yahoo.com
Will Generic Drug Tariffs Impact Pharma ETFs?
30-07-2026
yahoo.com
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?
19-08-2026
247wallst.com
PPHE Hotel Group H1 Earnings Call Highlights
27-08-2026
marketbeat.com
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
27-08-2026
yahoo.com
Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
01-09-2026
yahoo.com
PPHE Hotel Group Ltd (LSE:PPH) (H1 2026) Earnings Call Highlights: Strategic Review Ends ...
02-09-2026
yahoo.com
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
07-09-2026
yahoo.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
05-10-2026
yahoo.com
Execution of Pharma Tariffs Brings These ETFs Into Focus
06-10-2026
yahoo.com
What is the current price of VANECK PHARMACEUTICAL ETF (PPH:NASDAQ)?
The current price of VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) is $114.4061.
VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) since the previous trading day is $0.2961.
VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) since the previous trading day is 0.2595%.
What is the most recent average sentiment score for VANECK PHARMACEUTICAL ETF (PPH:NASDAQ)?
The most recent average sentiment score for VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for VANECK PHARMACEUTICAL ETF (PPH:NASDAQ)?
The most recent sentiment for VANECK PHARMACEUTICAL ETF (PPH:NASDAQ) is .
SEC-8K** Filing Available For VANECK PHARMACEUTICAL ETF (PPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.